Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Sarcoma 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 28Prostatic Neoplasms 14Neoplasm Metastasis 12Osteoporosis 8Multiple Myeloma 8Pain 7Lung Neoplasms 4Fractures, Bone 4Carcinoma, Non-Small-Cell Lung 4Neoplasms, Plasma Cell 3Humoral Hypercalcemia Of Malignancy 3Bone Neoplasms 3Bone Diseases, Metabolic 3Spinal Cord Compression 2Neoplasms 2Lymphoma 2Hematologic Neoplasms 2Triple Negative Breast Neoplasms 1Treatment of Bone Metastases 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Sarcoma 1Paraproteinemias 1Osteosarcoma 1Neoplastic Processes 1Lymphoma, Non-Hodgkin 1Imaging Examination Shows at Least One Site With Bone Metastases From Soild Tumors 1Hematologic Diseases 1Giant Cell Tumor of Bone 1Disease Progression 1

Interventions

Zoledronic Acid 2Denosumab 2Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Spinal Cord Compression × Zoledronic Acid × Clear all
NCT01345019 2022-11-08

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma

Amgen

Phase 3 Completed
1,718 enrolled 22 charts
Other hematologic neoplasmPlasma cellSarcoma

Blood Protein Disorders, Bone Diseases, Bone Marrow Diseases, Bone Neoplasms, Hematologic Diseases, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Neoplastic Processes, Paraproteinemias, Spinal Cord Compression, Hematologic Neoplasms, Fractures, Bone, Neoplasms, Plasma Cell

NCT00330759 2022-11-07

Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma.

Amgen

Phase 3 Completed
1,779 enrolled 14 charts
LymphoidPlasma cell

Lymphoma, Multiple Myeloma, Spinal Cord Compression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡